CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease. [electronic resource]
- Journal of Alzheimer's disease : JAD 2020
- 1585-1595 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1875-8908
10.3233/JAD-190753 doi
Aged Aged, 80 and over Alzheimer Disease--genetics Apolipoprotein E4--genetics Biomarkers--blood Chemokines, CC--blood Cognitive Dysfunction--genetics Cross-Sectional Studies Disease Progression Early Diagnosis Female Genotype Humans Kaplan-Meier Estimate Longitudinal Studies Male Mental Status and Dementia Tests Middle Aged Predictive Value of Tests